{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:29:24Z","timestamp":1793017764479,"version":"4.5.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LQ15H080002"],"award-info":[{"award-number":["LQ15H080002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Peripheral T cell lymphoma, coexisting with Castleman's disease (CD), is rarely seen in clinical practice and is not frequently reported in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 68-year-old female was admitted to our hospital for the first time due to \u201cmultiple lumps in the neck that progressively enlarged over 7 months\u201d. 1.5 years later, the patient returned to our hospital complaining of \u201c difficulty breathing and purulent blood in the mouth for more than 20 days\u201d.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The postoperative pathology from the (right) cervical lymph node biopsy confirmed the diagnosis of Castleman Disease (Vascular follicular type). 1.5 years after the diagnosis of CD, the patient developed secondary peripheral T cell lymphoma of unspecified type (PTCL-U).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received 5 courses of chemotherapy: 2 courses of CHOP, Chidamide combined with GemOx, GDP and Hyper CVAD Bregimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 3 courses of treatment, the curative effect was partly remitted (PR). The patient was discharged in a good condition and the follow-up was uneventful.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The mechanism responsible for CD concurrent or secondary lymphoma is not clear. Epstein-Barr virus (EBV) infection may be the most common reason of CD and PTCL-U. Further understanding the mechanisms of the condition is needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018650","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T17:33:41Z","timestamp":1578504821000},"page":"e18650","source":"Crossref","is-referenced-by-count":7,"title":["Peripheral T cell lymphoma coexisting with Castleman's disease"],"prefix":"10.1097","volume":"99","author":[{"given":"Shuyan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwen","family":"Wang","sequence":"additional","affiliation":[{"name":"First Clinical Medicine College, Zhejiang Chinese Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3109\/10428194.2014.953145","article-title":"Use of a claims database to characterize and estimate the incidence rate for Castleman disease","volume":"56","author":"Munshi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12185-013-1358-0","article-title":"Discordant lymphocyte-depleted classical Hodgkin's and peripheral T-cell lymphoma arising in a patient 11 years after diagnosis of multicentric Castleman's disease","volume":"98","author":"Park","year":"2013","journal-title":"Int J Hematol"},{"key":"R4-20230915","first-page":"225","article-title":"Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides","volume":"1","author":"Haap","year":"2017","journal-title":"Blood Rev"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma\u2013associated herpesvirus\u2013related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V86.3.1131.1131","article-title":"Molecular analysis of clonality in Castleman's disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/cid\/cis1009","article-title":"Human herpesvirus 8-Related Castleman disease in the absence of HIV infection","volume":"56","author":"Dossier","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1086\/374663","article-title":"Epstein-barr virus and human herpesvirus 8 coinfection and concomitant extranodal nasal-type NK\/T cell lymphoma and castleman disease: case report","volume":"36","author":"Larroche","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0065-230X(08)60319-X","article-title":"The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field","volume":"62","author":"Pallesen","year":"1993","journal-title":"Adv Cancer Res"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-Cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3892\/mco.2014.368","article-title":"Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK\/T-cell lymphoma","volume":"2","author":"Guo","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3109\/10428194.2012.739286","article-title":"Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma","volume":"54","author":"Yao","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12032-014-0860-4","article-title":"Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE\/IIE ectranodal natural killer\/T cell lynphoma: a retrospective study in a cohort of 227 patients with long-term follow-up","volume":"31","author":"Wang","year":"2014","journal-title":"Med Oncol"},{"key":"R16-20230915","first-page":"1","article-title":"Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas","volume":"1","author":"Jia","year":"2016","journal-title":"Hematology"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","article-title":"Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma","volume":"26","author":"Shi","year":"2015","journal-title":"Ann Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:35:15Z","timestamp":1694820915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018650"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018650","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}